Biblio

Export 1129 results:
Author [ Title(Asc)] Type Year
Filters: First Letter Of Last Name is T  [Clear All Filters]
A B C D E F G H I J K L M N O P Q R S T U V W X Y Z 
R
W. Wharton, Goldstein, F. C., Tansey, M. G., Brown, A. L., Tharwani, S. D., Verble, D. D., Cintron, A., and Kehoe, P. G., “Rationale and Design of the Mechanistic Potential of Antihypertensives in Preclinical Alzheimer's (HEART) Trial.”, J Alzheimers Dis, vol. 61, no. 2, pp. 815-824, 2018.
W. Wharton, Goldstein, F. C., Tansey, M. G., Brown, A. L., Tharwani, S. D., Verble, D. D., Cintron, A., and Kehoe, P. G., “Rationale and Design of the Mechanistic Potential of Antihypertensives in Preclinical Alzheimer's (HEART) Trial.”, J Alzheimers Dis, vol. 61, no. 2, pp. 815-824, 2018.
M. - S. Tan, Zhu, J. - X., Cao, X. - P., Yu, J. - T., and Tan, L., “Rare Variants in PLD3 Increase Risk for Alzheimer's Disease in Han Chinese.”, J Alzheimers Dis, vol. 64, no. 1, pp. 55-59, 2018.
M. - S. Tan, Zhu, J. - X., Cao, X. - P., Yu, J. - T., and Tan, L., “Rare Variants in PLD3 Increase Risk for Alzheimer's Disease in Han Chinese.”, J Alzheimers Dis, vol. 64, no. 1, pp. 55-59, 2018.
M. R. Farlow, Thompson, R. E., Wei, L. - J., Tuchman, A. J., Grenier, E., Crockford, D., Wilke, S., Benison, J., and Alkon, D. L., “A Randomized, Double-Blind, Placebo-Controlled, Phase II Study Assessing Safety, Tolerability, and Efficacy of Bryostatin in the Treatment of Moderately Severe to Severe Alzheimer's Disease.”, J Alzheimers Dis, vol. 67, no. 2, pp. 555-570, 2019.
M. R. Farlow, Thompson, R. E., Wei, L. - J., Tuchman, A. J., Grenier, E., Crockford, D., Wilke, S., Benison, J., and Alkon, D. L., “A Randomized, Double-Blind, Placebo-Controlled, Phase II Study Assessing Safety, Tolerability, and Efficacy of Bryostatin in the Treatment of Moderately Severe to Severe Alzheimer's Disease.”, J Alzheimers Dis, vol. 67, no. 2, pp. 555-570, 2019.
T. Yan, Wang, L., Gao, J., Siedlak, S. L., Huntley, M. L., Termsarasab, P., Perry, G., Chen, S. G., and Wang, X., “Rab10 Phosphorylation is a Prominent Pathological Feature in Alzheimer's Disease.”, J Alzheimers Dis, vol. 63, no. 1, pp. 157-165, 2018.
Q
S. Tiepolt, Schäfer, A., Rullmann, M., Roggenhofer, E., Gertz, H. - J., Schroeter, M. L., Patt, M., Bazin, P. - L., Jochimsen, T. H., Turner, R., Sabri, O., and Barthel, H., “Quantitative Susceptibility Mapping of Amyloid-β Aggregates in Alzheimer's Disease with 7T MR.”, J Alzheimers Dis, vol. 64, no. 2, pp. 393-404, 2018.
S. Tiepolt, Schäfer, A., Rullmann, M., Roggenhofer, E., Gertz, H. - J., Schroeter, M. L., Patt, M., Bazin, P. - L., Jochimsen, T. H., Turner, R., Sabri, O., and Barthel, H., “Quantitative Susceptibility Mapping of Amyloid-β Aggregates in Alzheimer's Disease with 7T MR.”, J Alzheimers Dis, vol. 64, no. 2, pp. 393-404, 2018.
J. C. Triplett, Swomley, A. M., Cai, J., Klein, J. B., and D Butterfield, A., “Quantitative phosphoproteomic analyses of the inferior parietal lobule from three different pathological stages of Alzheimer's disease.”, J Alzheimers Dis, vol. 49, no. 1, pp. 45-62, 2016.
C. Groot, Tolboom, N., Ikonomovic, M. D., Lammertsma, A. A., Boon, B. D. C., Barkhof, F., Scheltens, P., Klunk, W. E., Rozemuller, A. J. M., Ossenkoppele, R., and van Berckel, B. N. M., “Quantitative PET and Histology of Brain Biopsy Reveal Lack of Selective Pittsburgh Compound-B Binding to Intracerebral Amyloidoma.”, J Alzheimers Dis, 2018.
O. Snytnikova, Telegina, D., Savina, E., Tsentalovich, Y., and Kolosova, N., “Quantitative Metabolomic Analysis of the Rat Hippocampus: Effects of Age and of the Development of Alzheimer's Disease-Like Pathology.”, J Alzheimers Dis, vol. 99, no. s2, pp. S327-S344, 2024.
O. Snytnikova, Telegina, D., Savina, E., Tsentalovich, Y., and Kolosova, N., “Quantitative Metabolomic Analysis of the Rat Hippocampus: Effects of Age and of the Development of Alzheimer's Disease-Like Pathology.”, J Alzheimers Dis, vol. 99, no. s2, pp. S327-S344, 2024.
M. Ramos de Matos, Ferreira, C., Herukka, S. - K., Soininen, H., Janeiro, A., Santana, I., Baldeiras, I., Almeida, M. Rosário, Lleo, A., Dols-Icardo, O., Alcolea, D., Benussi, L., Binetti, G., Paterlini, A., Ghidoni, R., Nacmias, B., Meulenbroek, O., van Doorn, L. J. C. van Wa, H Kuiperi, B. J., Hausner, L., Waldemar, G., Simonsen, A. Hviid, Tsolaki, M., Gkatzima, O., de Oliveira, C. Resende, Verbeek, M. M., Clarimón, J., Hiltunen, M., de Mendonça, A., and Martins, M., “Quantitative Genetics Validates Previous Genetic Variants and Identifies Novel Genetic Players Influencing Alzheimer's Disease Cerebrospinal Fluid Biomarkers.”, J Alzheimers Dis, vol. 66, no. 2, pp. 639-652, 2018.
É. M. Foley, Tripodis, Y., Yhang, E., Koerte, I. K., Martin, B. M., Palmisano, J., Makris, N., Schultz, V., Lepage, C., Muehlmann, M., Wróbel, P. P., Guenette, J. P., Cantu, R. C., Lin, A. P., Coleman, M., Mez, J., Bouix, S., Shenton, M. E., Stern, R. A., and Alosco, M. L., “Quantifying and Examining Reserve in Symptomatic Former National Football League Players.”, J Alzheimers Dis, vol. 85, no. 2, pp. 675-689, 2021.
C. J. Huseby, Hoffman, C. N., Cooper, G. L., Cocuron, J. - C., Alonso, A. P., Thomas, S. N., Yang, A. J., and Kuret, J., “Quantification of Tau Protein Lysine Methylation in Aging and Alzheimer's Disease.”, J Alzheimers Dis, vol. 71, no. 3, pp. 979-991, 2019.
P
A. Jacquin-Piques, Sacco, G., Tavassoli, N., Rouaud, O., Bejot, Y., Giroud, M., Robert, P., Vellas, B., and Bonin-Guillaume, S., “Psychotropic Drug Prescription in Patients with Dementia: Nursing Home Residents Versus Patients Living at Home.”, J Alzheimers Dis, vol. 49, no. 3, pp. 671-80, 2016.
A. R. Sutin, Stephan, Y., and Terracciano, A., “Psychological Distress, Self-Beliefs, and Risk of Cognitive Impairment and Dementia.”, J Alzheimers Dis, vol. 65, no. 3, pp. 1041-1050, 2018.
S. Ismail, Christopher, G., Dodd, E., Wildschut, T., Sedikides, C., Ingram, T. A., Jones, R. W., Noonan, K. A., Tingley, D., and Cheston, R., “Psychological and Mnemonic Benefits of Nostalgia for People with Dementia.”, J Alzheimers Dis, vol. 65, no. 4, pp. 1327-1344, 2018.
S. E. O'Bryant, Zhang, F., Petersen, M., Hall, J. R., Johnson, L. A., Yaffe, K., Braskie, M., Vig, R., Toga, A. W., and Rissman, R. A., “Proteomic Profiles of Neurodegeneration Among Mexican Americans and Non-Hispanic Whites in the HABS-HD Study.”, J Alzheimers Dis, vol. 86, no. 3, pp. 1243-1254, 2022.
T. Alves Sarno, Talib, L. Leme, Joaquim, H. Passarelli, Bram, J. Maria de F., Gattaz, W. Farid, and Forlenza, O. Vicente, “Protein Expression of BACE1 is Downregulated by Donepezil in Alzheimer's Disease Platelets.”, J Alzheimers Dis, vol. 55, no. 4, pp. 1445-1451, 2017.
H. P Reddy, Manczak, M., Yin, X. L., Grady, M. Catherine, Mitchell, A., Tonk, S., Kuruva, C. Sekhar, Bhatti, J. Singh, Kandimalla, R., Vijayan, M., Kumar, S., Wang, R., Pradeepkiran, J. Adi, Ogunmokun, G., Thamarai, K., Quesada, K., Boles, A., and Reddy, A. P., “Protective Effects of Indian Spice Curcumin Against Amyloid-β in Alzheimer's Disease.”, J Alzheimers Dis, vol. 61, no. 3, pp. 843-866, 2018.
H. P Reddy, Manczak, M., Yin, X. L., Grady, M. Catherine, Mitchell, A., Tonk, S., Kuruva, C. Sekhar, Bhatti, J. Singh, Kandimalla, R., Vijayan, M., Kumar, S., Wang, R., Pradeepkiran, J. Adi, Ogunmokun, G., Thamarai, K., Quesada, K., Boles, A., and Reddy, A. P., “Protective Effects of Indian Spice Curcumin Against Amyloid-β in Alzheimer's Disease.”, J Alzheimers Dis, vol. 61, no. 3, pp. 843-866, 2018.
N. M. E. Scheltens, Tijms, B. M., Heymans, M. W., Rabinovici, G. D., Cohn-Sheehy, B. I., Miller, B. L., Kramer, J. H., Wolfsgruber, S., Wagner, M., Kornhuber, J., Peters, O., Scheltens, P., and van der Flier, W. M., “Prominent Non-Memory Deficits in Alzheimer's Disease Are Associated with Faster Disease Progression.”, J Alzheimers Dis, 2018.
M. F. Mendez, Moheb, N., Desarzant, R. E., and Teng, E. H., “The Progressive Acalculia Presentation of Parietal Variant Alzheimer's Disease.”, J Alzheimers Dis, vol. 63, no. 3, pp. 941-948, 2018.

Pages